News

Daratumumab-lenalidomide maintenance enhances MRD-negative conversion and reduces progression in multiple myeloma patients regardless of age, race, or cytogenetic risk.

PUFA-rich and Nordic diets reduce liver fat and LDL cholesterol over 12 months, with broader metabolic benefits seen with the Nordic diet.

After 1 year, 13 of 17 patients in the 30 mg group tolerated at least 443 mg peanut protein, compared with none in the avoidance group. Similar improvements were observed in the 300 mg group.

Molecular profiling and matched targeted treatment significantly improved survival in advanced cholangiocarcinoma in a large Italian real-world study.

New data identify age, anti-β2GP1 antibodies, and low C3 as key risk factors for cerebral small vessel disease in systemic lupus erythematosus, highlighting the need for targeted screening and risk stratification.

The results suggest that treatment once weekly with semaglutide could reduce the frequency and duration of hospital admissions for patients at high cardiovascular risk…

In 2026, the beleaguered, aging National Health Service (NHS) of England is on the precipice of major changes in staffing models and digital implementations.

An optimised OFA/iLRP aptamer forms a DNA nanostructure delivering doxorubicin selectively to AML cells, improving efficacy and reducing toxicity in preclinical models.